tacrolimus
Showing 51 - 75 of 572
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021
Heart Transplantation Trial in New York (Belatacept, Tacrolimus, Mycophenolate Mofetil)
Recruiting
- Heart Transplantation
- Belatacept
- +3 more
-
New York, New YorkVallesky Berrich
Sep 17, 2021
Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +6 more
- (no location specified)
Dec 28, 2022
Heart Transplantation Trial in Los Angeles (Thymoglobulin, Mycophenolate Mofetil, Tacrolimus)
Enrolling by invitation
- Heart Transplantation
- Thymoglobulin
- +4 more
-
Los Angeles, California
- +1 more
Nov 11, 2022
Alterations in Cognitive Function and Cerebral Blood Flow After
Completed
- End Stage Renal Disease
- Envarsus
- Tacrolimus
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 26, 2021
Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)
Completed
- Rheumatoid Arthritis (RA)
- tacrolimus
- +4 more
-
Daegu, Korea, Republic of
- +9 more
Aug 26, 2021
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,
Active, not recruiting
- Pediatric Heart Transplantation
- +6 more
- Everolimus
- +2 more
-
Birmingham, Alabama
- +24 more
Sep 2, 2021
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Renal Transplant Rejection, Kidney Transplant Failure and Rejection Trial in New York (Tacrolimus Extended Release Oral Tablet,
Active, not recruiting
- Renal Transplant Rejection
- Kidney Transplant Failure and Rejection
- Tacrolimus Extended Release Oral Tablet
- Tacrolimus
-
New York, New YorkColumbia University Medical Center
Jan 26, 2021
Vitiligo Trial in France (tacrolimus, Placebo)
Completed
- Vitiligo
- tacrolimus
- Placebo
-
Bordeaux, France
- +3 more
Apr 16, 2021
Nephrotic Syndrome Trial in Kolkata (Rituximab, Tacrolimus)
Recruiting
- Nephrotic Syndrome
- Rituximab
- Tacrolimus
-
Kolkata, West Bengal, IndiaNRS Medical College & Hospital
Apr 6, 2022
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Liver Transplant, Kidney Transplant Trial in Los Angeles, Gainesville, Singapore (PPM-based Computation Assisted Drug Dosing,
Completed
- Liver Transplant
- Kidney Transplant
- PPM-based Computation Assisted Drug Dosing
- Tacrolimus
-
Los Angeles, California
- +2 more
Dec 9, 2021
Hypertrophy, Left Ventricular Trial in L'Hospitalet de Llobregat (Everolimus, Mycophenolate mofetil, Tacrolimus)
Completed
- Hypertrophy, Left Ventricular
- Everolimus
- +2 more
-
L'Hospitalet de Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Jan 7, 2021
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
-
Birmingham, Alabama
- +38 more
Oct 25, 2021
Antisynthetase Syndrome (ASS), Interstitial Lung Disease Trial in Paris (Cyclophosphamide and azathioprine, Tacrolimus)
Recruiting
- Antisynthetase Syndrome (ASS)
- Interstitial Lung Disease
- Cyclophosphamide and azathioprine
- Tacrolimus
-
Paris, FranceHôpital Universitaire Pitié Salpêtrière
Feb 6, 2021
MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Venetoclax
- +4 more
-
Aachen, NRW, Germany
- +2 more
Mar 29, 2023
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022